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Abstract
Objectives Several intracranial vessel wall sequences have
been described in recent literature, with either 3-Tor 7-T mag-
netic resonance imaging (MRI). In the current study, we com-
pared 3-T and 7-T MRI in visualising both the intracranial
arterial vessel wall and vessel wall lesions.
Methods Twenty-one elderly asymptomatic volunteers were
scanned by 3-T and 7-T MRI with an intracranial vessel wall
sequence, both before and after contrast administration. Two
raters scored image quality, and presence and characteristics
of vessel wall lesions.
Results Vessel wall visibility was equal or significantly better
at 7 T for the studied arterial segments, even though there were
more artefacts hampering assessment. The better visualisation
of the vessel wall at 7 T was most prominent in the proximal
anterior cerebral circulation and the posterior cerebral artery.
In the studied elderly asymptomatic population, 48 vessel-
wall lesions were identified at 3 T, of which 7 showed en-
hancement. At 7 T, 79 lesions were identified, of which 29
showed enhancement. Seventy-one percent of all 3-T lesions
and 59 % of all 7-T lesions were also seen at the other field
strength.
Conclusions Despite the large variability in detected lesions
at both field strengths, we believe 7-T MRI has the highest
potential to identify the total burden of intracranial vessel wall
lesions.
Key Points
• Intracranial vessel wall visibility was equal or significantly
better at 7-T MRI
• Most vessel wall lesions in the cerebral arteries were found
at 7-T MRI
• Many intracranial vessel wall lesions showed enhancement
after contrast administration
• Large variability in detected intracranial vessel wall lesions
at both field strengths
• Seven-tesla MRI has the highest potential to identify total
burden of intracranial atherosclerosis
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Introduction
Intracranial atherosclerosis is one of the main causes of isch-
aemic stroke and transient ischaemic attack (TIA), and has
been associated with a higher risk of recurrent stroke [1, 2].
Current standard non-invasive imaging methods, like comput-
ed tomography (CT) angiography, visualise the lumen of the
intracranial vasculature instead of its vessel wall, thereby
risking underestimation of intracranial atherosclerosis in isch-
aemic stroke [3–6] due to compensatory arterial remodelling
that maintains lumen diameter [4, 7]. Therefore, several mag-
netic resonance imaging (MRI) sequences have recently been
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developed for direct evaluation of the intracranial vessel wall
and its pathology in vivo [8]. Studies have shown that high-
resolution MRI is able to identify intracranial vessel wall ab-
normalities even before causing luminal narrowing.
Intracranial vessel wall imaging has been performed main-
ly at 3.0- and 7.0-tesla (T) field strengths. At these higher
magnetic field strengths, the increased signal-to-noise (SNR)
and contrast-to-noise ratios (CNR) can be exploited for imag-
ing at a higher spatial resolution within reasonable scan times
to clearly show the thin arterial vessel walls, and for improve-
ment of lesion conspicuousness [7, 9]. Current challenges at 3
T are incomplete cerebrospinal fluid (CSF) suppression, po-
tentially limiting vessel wall assessment, and (often) limited
coverage [8, 10, 11]. Seven-tesla MRI offers the advantage of
an increased SNR, allowing for complete CSF suppression
and whole-brain imaging within clinically feasible scan times
[12]; its use, however, is currently hampered by restricted
availability and increased transmit field (B1
+) inhomogeneity,
causing artefacts that can limit vessel wall assessment [13]. The
implications of these differences are unclear, because a direct
comparison between intracranial vessel wall MRI at these field
strengths has not yet been performed. The purpose of this study
was to compare visualisation of the intracranial vessel wall and
possible vessel wall lesions between 3-T and 7-T MRI.
Methods
Study population
This prospective study was approved by the institutional re-
view board of our institution; all subjects provided written
informed consent. Between November 2013 and December
2014, volunteers aged >50 years, without a history of cerebro-
vascular or ischaemic heart disease or contraindications for
MR imaging, were included. These volunteers formed the con-
trol group of the ongoing PIVI study (Posterior Intracranial
Vessel wall Imaging; NTR5688, www.trialregister.nl).
Imaging
All subjects underwent MRI at both 3 Tand 7 T. For each field
strength, an optimised, T1-weighted intracranial vessel wall
imaging sequence was used; a previous ex vivo study at 7 T
[14] showed T1-weighted imaging to have the most promising
image contrast for visualising and characterising intracranial
arterial vessel wall lesions. In addition, a T1-weighted se-
quence enables assessment of vessel-wall contrast enhance-
ment. The sequence at 3 T had been optimised in volunteers
(data not shown) based on a previously published sequence by
Qiao et al. [10] The 7-T sequence had already been optimised
in previous studies [12, 15]. At both field strengths, the intra-
cranial vessel wall scan was performed before and after
contrast administration; a minimum of 12 h was taken be-
tween bothMRI examinations, to make sure the contrast agent
had washed out sufficiently, and care was taken that bothMRI
examinations were planned as close after each other as possi-
ble (median, 4 days; IQR, 3-9 days). The postcontrast vessel
wall scan was acquired approximately 5 min after intravenous
administration of 0.1 mL/kg of a gadolinium-containing con-
trast agent (Gadobutrol, Gadovist 1.0 mmol/mL; Bayer
Schering Pharma, Newbury, UK). For signal improvement
in the cerebellar region at 7 T, high permittivity dielectric pads
were used (Leiden University Medical Center, Leiden,
The Netherlands) [16, 17].
3-T MRI protocol
Imaging was performed on a 3-T whole-body system
(Achieva; Philips Healthcare, Best, The Netherlands), with a
quadrature body coil for transmission and an eight-channel
head coil for reception. The imaging protocol included a
three-dimensional (3D) T1-weighted volumetric isotropically
reconstructed turbo spin-echo acquisition (VIRTA) intracrani-
al vessel wall sequence (adapted from Qiao et al. [10] by
Dieleman et al., submitted for publication). The applied scan
parameters are presented in Table 1.
7-T MRI protocol
For 7-T MRI, a whole-body system (Philips Healthcare,
Cleveland, OH, USA) was used with a 32-channel receive coil
and volume transmit/receive coil for transmission (Nova
Medical, Wilmington, MA, USA). The imaging protocol in-
cluded a 3Dwhole-brain T1-weighted magnetisation-prepared
inversion recovery turbo spin echo (MPIR-TSE) intracranial
vessel wall sequence [15]. The applied scan parameters are
presented in Table 1.
Image assessment
Images were assessed in the same format as they are normally
evaluated in clinical practice, which includes the ‘standard’
image interpolation performed by the scanner software.
Multiplanar reconstructions (MPRs) were made from the
vessel-wall scans acquired at 3 T (thickness, 1.0 mm; no slice
gap) and 7 T (thickness, 0.8 mm; no slice gap), using a
standalone workstation (Philips). The used slice thickness
was based on the acquired resolution in the slice direction.
To obtain the same data sets for further analysis, the 7-T ves-
sel-wall MPRs were made using the spatial orientation of the
3-T images.
Three-tesla and 7-T MPR images were evaluated in ran-
dom order by two trained raters (A.K. and A.H.), with 6 and
3 years of experience in assessing intracranial vessel wall im-
ages, respectively, who were blinded for each other’s
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assessment and for the findings on the other (3-Tor 7-T) scan.
Each scan was analysed once by each rater; in case of dis-
agreement regarding vessel wall lesions, a consensus reading
was performed with a third rater (J.H.; 6 years of experience in
assessing intracranial vessel wall images). After consensus,
non-corresponding vessel-wall lesions at 3 T and 7 T were
assessed in a side-by-side comparison.
The assessed vessel segments included: anterior cerebral
artery (ACA; A1 and A2 segments); anterior communicating
artery (ACoA); middle cerebral artery (MCA; M1, M2 and
M3 segments); internal carotid artery (ICA; distal intracranial
segment; intracranial bifurcation); posterior communicating
artery (PCoA); posterior cerebral artery (PCA; P1 segment,
bifurcation P1-P2 and P2 segment); basilar artery (BA; prox-
imal half, distal half and bifurcation with P1 segment); verte-
bral arteries (VA; proximal and distal half).
Image quality
Image quality was evaluated using the method modified from
Van der Kolk et al. [15], with three qualitative grading scales
for overall artefacts (0 = artefacts hampering assessment;
1 = moderate artefacts, but images assessable; 2 = no arte-
facts), overall visibility of the arterial vessel wall (0 = poor;
1 =moderate; 2 = good), and visibility of all separate arterial
vessel walls (0 = outside FOV; 1 = not visible; 2 = poor;
3 =moderate; 4 = good).
Vessel-wall lesions
Vessel-wall lesions were scored on the precontrast images
according to the methods previously described [12, 20] A
vessel-wall lesion was defined as either a clear focal or more
diffuse thickening of the vessel wall, compared with the
healthy contralateral or neighbouring vessel wall [21]. For
assessment of contrast enhancement, vessel wall images were
processed using MeVisLab (version 2.7; MeVis Medical
Solutions, Bremen, Germany). After coregistering the
postcontrast scan to the precontrast scan using elastix [22],
the precontrast scan was subtracted from the (coregistered)
postcontrast scan. The resulting subtracted images together
with the precontrast and postcontrast vessel wall images were
used for contrast enhancement assessment [12]. In addition to
contrast enhancement, specific lesion characteristics (config-
uration and thickening pattern) were also assessed [see
Electronic supplementary material (ESM)].
Statistical analysis
Differences between image quality ratings at 3 T and 7 Twere
calculated using a non-parametric Wilcoxon signed-rank test.
Table 1 Scan parameters of the
intracranial vessel wall imaging
sequence at 3 T and 7 T
Scan parameter 3-T VIRTAa 7-T MPIR-TSEb
FOV (mm3) 200 × 167 × 45 250 × 250 × 190
Acquisition orientation Transverse oblique Sagittal
Acquired spatial resolution (mm3) 0.6 × 0.6 × 1.0 0.8 × 0.8 × 0.8
Reconstructed spatial resolution (mm3) 0.5 × 0.5 × 0.5 0.49 × 0.49 × 0.49
TR / TE / TI (ms) 1,500 / 36 / - 3,952 / 37 / 1,375
Flip angle (degrees) 90 120
Echo spacing (ms) 4.0 3.3
TSE factor 62 (incl. 6 start-up) 169 (incl. 10 start-up)
Oversampling factor 1.8 1
NSA 1 2
SENSE factor 1.5 (RL) 2 (AP) & 3 (RL)
Acquisition time (min:s) 6:51 10:40
FOV field-of-view, MPIR-TSE magnetisation-prepared inversion recovery, NSA number of signal averages,
SENSE sensitivity encoding, TE echo time, TI inversion time, TR repetition time, TSE turbo spin echo, VIRTA
volumetric isotropically reconstructed turbo spin-echo acquisition
a Sequence was planned so that as much of the circle ofWillis as possible was within the FOV. Several parameters
were adapted/added to Qiao et al. [10]: TR = 1,500 ms and anti-DRIVen Equilibrium (DRIVE) module to increase
T1-weighting and CSF suppression; a low minimum flip angle (25 degrees) in the variable flip angle refocusing
pulse train for increased flow suppression [18]; interpolation factor = 2 by zero-padding in the slice direction
during reconstruction, slight adjustment of the acquired in-plane resolution, and reducing the TR to reduce scan
time further
b In comparison to previous studies [12, 15, 19], sequences were obtained with a dual transmit system that
provides a B1
+ in the brain that matches the nominal flip angle; therefore, all flip angles could be reduced by
20 % to obtain the same image contrast
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Inter-rater agreement of the number and location of vessel
wall lesions was evaluated using the Dice’s similarity coeffi-
cient (DSC) [23] for the 3-T and 7-T MR images separately.
For inter-rater agreement of contrast enhancement assessment
Cohen’s kappa was calculated. Statistical analyses were per-
formed using IBM SPSS Statistics (version 21; IBM
Corporation, Armonk, NY, USA). A p value of <0.05 was
considered to be statistically significant. Bonferroni correction
for multiple comparisons was applied when appropriate.
Results
Study population
Twenty-one healthy volunteers (12 men; age 66 ± 5 years)
were included. Baseline characteristics are shown in ESM
Table I.
Image quality
Since image quality ratings of both raters were comparable,
the mean of both raters was used. Seven-tesla images showed
significantly more artefacts compared with 3 T, both
precontrast and postcontrast (Table 2). For analysis of vessel
wall visibility, subjects scored with artefacts hampering as-
sessment on either 3-T or 7-T images where the majority of
the vessel walls were affected (i.e. due to severe motion arte-
facts) were excluded (n = 6; motion artefacts at 3 T (n = 2) or 7
T (n = 4); precontrast n = 2 and postcontrast n = 4). Overall
vessel wall visibility was scored significantly better for the
7-T images compared with 3 T, both precontrast and
postcontrast (Table 2). On arterial segment level (Table 3),
the ICA, ACA and proximal MCA (M1 segment) vessel walls
were significantly better visible at 7 T; this was also the case
for the P2 segment.
Vessel-wall lesions
For analysis of vessel-wall lesions, subjects with poor overall
vessel wall visibility scored by both raters on either 3-Tor 7-T
precontrast images were excluded [n = 5; poor visibility at 3 T
only (n = 1), 7 T only (n = 2), or both at 3 T and 7 T (n = 2)],
resulting in 16 subjects for analysis. For analysis of lesion
enhancement, an additional three subjects were excluded
based on poor overall visibility of the postcontrast scan [poor
visibility at 3 T only (n = 2) or 7 T only (n = 1)].
Pre-consensus inter-rater agreement for number and loca-
tion of the identified vessel-wall lesions was good at both 3 T
(DSC, 0.68) and 7 T (DSC, 0.67). Also, a good to excellent
Table 2 Qualitative
scoring of artefacts and
overall visibility of the
arterial vessel wall on 3-




3 T 7 T p-valuec 3 T 7 T p-valuec
Artefactsa
0 2 (5 %) 14 (33 %) 6 (14 %) 16 (38 %)
1 29 (69 %) 28 (67 %) 32 (76 %) 26 (62 %)
2 11 (26 %) 0 (0 %) 4 (10 %) 0 (0 %)
Proportion of overall agreement (%) 76 62 81 71
Mean rater 1 (range) 1.24 (0-2) 0.57 (0-1) 0.95 (0-2) 0.57 (0-1)
Mean rater 2 (range) 1.19 (0-2) 0.76 (0-1) 0.95 (0-2) 0.67 (0-1)
Mean both raters 1.21 0.67 <0.001 0.95 0.62 0.024
Overall visibility vessel wallb
0 5 (17 %) 3 (10 %) 5 (17 %) 3 (10 %)
1 22 (73 %) 11 (37 %) 23 (77 %) 14 (47 %)
2 3 (10 %) 16 (53 %) 2 (7 %) 13 (43 %)
Proportion of overall agreement (%) 60 80 80 87
Mean rater 1 (range) 0.87 (0-2) 1.40 (0-2) 0.93 (0-2) 1.33 (0-2)
Mean rater 2 (range) 1.00 (0-2) 1.47 (0-2) 0.87 (0-2) 1.33 (0-2)
Mean both raters 0.93 1.43 0.009 0.90 1.33 0.019
Grading scale overall artefacts: 0 = artefacts hampering assessment; 1 =moderate artefacts, but images assessable; 2 = no
artefacts
Grading scale overall visibility of the arterial vessel wall: 0 = poor; 1 =moderate; 2 = good
a Based on 21 subjects
b Based on 15 subjects
c Bonferroni corrected significance level p < 0.025 (corrected for two comparisons of rating scales)
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inter-rater agreement was found for lesion contrast enhance-
ment (kappa 0.85 for 3 T, and 0.67 for 7 T). On the precontrast
scans, 45 (at 3 T) and 67 (at 7 T) vessel-wall lesions were
scored after consensus; an additional 3 (at 3 T) and 12 (at 7
T) lesions were identified because of vessel-wall enhance-
ment. In total, 48 vessel-wall lesions were identified at 3 T
(mean, 3 per subject; range, 1-7), of which 7 (15 %) showed
enhancement (Table 4). At 7 T, 79 lesions were identified
(mean, 5 per subject; range, 1-10), of which 29 (37%) showed
enhancement (Table 4).
Side-by-side comparison
Twenty-four vessel wall lesions were identified at both 3 Tand
7 T (Figs. 1 and 2). Almost one-third (7/24; 29 %) of lesions
visible at both 3 T and 7 T showed enhancement on both field
strengths; an additional one-third (9/24; 38 %) showed en-
hancement at 7 Tonly. Most corresponding lesions were pres-
ent in the vertebral arteries, basilar artery and internal carotid
arteries.
Side-by-side comparison of the non-corresponding vessel-
wall lesions showed that in retrospect, 10 lesions (21 %)
scored only at 3 T and 23 lesions (29 %) scored only at 7 T
were either visible retrospectively but missed at the other field
strength by both raters, or identified but omitted during the
consensus reading (Fig. 3). Fourteen (29 %) vessel-wall le-
sions that were identified at 3 T could not be retrospectively
identified at 7 T. At 7 T, 32 (41 %) vessel wall lesions could
not be retrospectively identified at 3 T (Fig. 4). The non-
corresponding lesions were mainly located in areas where
the vessel wall was less well visible; also, several of these
lesions appeared smaller compared with the corresponding
lesions. In total, 34 (71 %) of all lesions identified at 3 T (24
after consensus + 10 in retrospect) and 47 (59 %) at 7 T (24
after consensus + 23 in retrospect) were also seen on the other
field strength.
Discussion
In the current study, vessel wall visibility was equal or signif-
icantly better at 7 T compared with 3 T for the studied arterial
segments, even though there were more artefacts hampering
assessment at 7 T. Furthermore, more vessel wall lesions were
scored on 7-T images. However, surprisingly, only 71 % of all
3-T lesions were seen at 7 T.
Better visualisation of the vessel wall at 7 T was most
prominent in the proximal anterior cerebral circulation and
the P2 segment of the PCA; the basilar artery and vertebral
arteries were visualised equally good at both field strengths.
The latter could be explained by better CSF suppression in this
region compared to other brain regions at 3 T, probably be-
cause of higher local CSF flow pulsation. Artefacts at 7 Twere
mainly caused by motion artefacts or signal loss and B1
+ in-
homogeneities in the areas of the temporal lobes and cerebel-
lum. Although motion artefacts were also present at 3 T, they
occurred more frequently at 7 T. This might be related to the
longer acquisition time of the 7-T sequence compared with 3
T, increasing the possibility of subject motion during scanning
[24]. B1
+ inhomogeneities at 7 T result in a spatially varying
SNR and contrast that is most pronounced at the temporal
lobes and cerebellum [13, 16]. In this study, dielectric bags
were placed in the upper neck region of the subjects to im-
prove imaging of the cerebellar region, which improved part
of the signal loss, but did not reduce signal loss in all subjects.
Most vessel wall lesions were found using 7 T, which was
expected since CSF suppression is better at 7 T than at 3 T in
most brain regions. At 3 T, no explicit CSF suppression can be
Table 3 Qualitative visibility scoring of all separate arterial vessel wall
segments of the circle of Willis and its primary branches on 3-T and 7-T
MRI (precontrast)a
Location 3 T 7 T p - valueb
Anterior cerebral artery
A1 segment 2.21 (1-3) 2.79 (2-4) 0.001*
A2 segment 1.63 (1-3) 2.24 (1-4) <0.001*
Anterior communicating artery 1.16 (1-2) 1.32 (1-3) 0.398
Middle cerebral artery
M1 segment 2.11 (1-3) 2.76 (2-4) <0.001*
M2 segment 2.16 (1-3) 2.24 (1-3) 0.802
M3 segment 1.34 (0-3) 1.05 (0-2) 0.052c
Internal carotid artery
Distal intracranial segment 2.82 (2-3) 3.37 (2-4) 0.002*
Intracranial bifurcation 2.61 (2-4) 3.16 (2-4) <0.001*
Posterior communicating artery 1.90 (1-3) 2.50 (1-4) 0.083
Posterior cerebral artery
P1 segment 2.55 (1-4) 3.13 (2-4) 0.003
Bifurcation 2.26 (1-4) 3.08 (2-4) 0.004
P2 segment 1.79 (1-3) 2.63 (2-3) <0.001*
Basilar artery
Bifurcation 2.74 (1-4) 2.90 (1-4) 0.413
Distal half 2.97 (2-4) 2.90 (1-4) 0.499
Proximal half 3.11 (1-4) 2.97 (1-4) 0.545
Vertebral artery
Distal half 3.26 (2-4) 2.84 (1-4) 0.168
Proximal half 3.32 (2-4) 2.97 (1-4) 0.214
*statistically significant (after Bonferroni correction)
Scores are given as mean (range) of both raters
Grading scale: 0 = outside FOV; 1 = not visible; 2 = poor; 3 =moderate;
4 = good
a Based on 19 subjects per location
b Bonferroni corrected significance level p < 0.003 (corrected for 17 com-
parisons of arterial segments)
c Rating B0^ was excluded from statistical analysis (n = 3 subjects)
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performed; therefore, suppression depends on the amount of
CSF flow during the spin echo train which is spatially depen-
dent, resulting in varying quality of CSF suppression in dif-
ferent brain regions. The 7-T sequence contains a non-
selective adiabatic inversion pulse for global CSF suppres-
sion. Most corresponding lesions between 3 T and 7 T were
present in the vertebral arteries, basilar artery, and internal
carotid arteries: all larger arterial segments of the circle of
Willis around which considerable CSF flow pulsation is pres-
ent. These segments scored relatively good for vessel wall
visibility at both 3 T and 7 T.
Close to one-half of 7-T lesions (41 %) could not be iden-
tified at 3-T MRI. On the other hand, a striking one-third
(29 %) of all lesions identified at 3 T were not visible at 7 T.
The latter might be explained by the higher acquired in-plane
spatial resolution of the 3-T sequence (0.6 × 0.6 mm2) com-
pared with the 7-T sequence (0.8 × 0.8 mm2), so that very
small lesions seen at 3 T might have been missed at 7 T. The
first could be explained by the increased SNR and CNR as
well as better CSF suppression at 7 T. Another possible ex-
planation, applicable to both findings, could be that for small-
er lesions we are currently at the edge of what can be
visualised with the used vessel wall imaging sequences. For
these small lesions, scan parameter differences between both
field strengths (e.g. slice thickness, voxel sizes) as well as field
inhomogeneities may become more important [25].
Table 4 Overview of number, location and enhancement of identified vessel wall lesions on 3-T and 7-T vessel wall images, as well as lesions that
corresponded between 3 T and 7 T
3 T 7 T Corresponding 3 T-7 T
Lesions Enhancementa Lesions Enhancementb Lesions Enhancementc
Location 3 T 7 T
Total anterior circulation 17 (35.4) 1 32 (40.5) 8 7 1 4
Anterior cerebral artery 3 (6.3) 0 3 (3.8) 0 0 0 0
A1 segment 2 (4.2) 0 1 (1.3) 0 0 0 0
A2 segment 1 (2.1) 0 2 (2.5) 0 0 0 0
Anterior communicating artery 0 (0.0) 0 0 (0.0) 0 0 0 0
Middle cerebral artery 6 (12.5) 1 13 (16.5) 2 3 1 2
M1 segment 5 (10.4) 1 9 (11.4) 2 3 1 2
M2 segment 1 (2.1) 0 4 (5.1) 0 0 0 0
M3 segment 0 (0.0) 0 0 (0.0) 0 0 0 0
Internal carotid artery 8 (16.7) 0 16 (20.3) 6 4 0 2
Distal intracranial segment 3 (6.3) 0 6 (7.6) 3 1 0 1
Intracranial bifurcation 5 (10.4) 0 10 (12.7) 3 3 0 1
Total posterior circulation 31 (64.6) 6 47 (59.5) 21 17 6 12
Posterior communicating artery 2 (4.2) 0 2 (2.5) 0 1 0 0
Posterior cerebral artery 4 (8.3) 0 11 (13.9) 1 1 0 0
P1 segment 2 (4.2) 0 0 (0.0) 0 0 0 0
Bifurcation 0 (0.0) 0 4 (5.1) 0 0 0 0
P2 segment 2 (4.2) 0 7 (8.9) 1 1 0 0
Basilar artery 8 (16.7) 0 10 (12.7) 3 4 0 2
Bifurcation 5 (10.4) 0 5 (6.3) 1 2 0 1
Distal half 3 (6.3) 0 2 (2.5) 1 2 0 1
Proximal half 0 (0.0) 0 3 (3.8) 1 0 0 0
Vertebral artery 17 (35.4) 6 24 (30.4) 17 11 6 10
Distal half 3 (6.3) 0 6 (7.6) 3 1 0 1
Proximal half 14 (29.2) 6 18 (22.8) 14 10 6 9
Total 48 7 79 29 24 7 16
Number of lesions per location (% from total)
a n = 7 lesions not assessable on postcontrast scans
b n = 13 lesions not assessable on postcontrast scans
c n = 3 lesions not assessable on postcontrast scans
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Consequently, both SNR and CNR may become too low to
reliably differentiate lesions from noise, resulting in more sub-
jective assessment. Also, there might be a higher risk of
misinterpreting vessel wall irregularities caused by other phe-
nomena like slow flow directly alongside the artery mimick-
ing a lesion, or incomplete CSF suppression [11, 26, 27]. In
Fig. 1 Corresponding vessel-
wall lesions at 3 T and 7 T
(arrows) on the precontrast
images: located at the left distal
intracranial segment of the ICA
(a), right P2 segment of the PCA
(b) and left M1 segment of the
MCA (c). ICA intracranial
internal carotid artery, MCA
middle cerebral artery, PCA
posterior cerebral artery
Fig. 2 Vessel-wall enhancement after contrast administration. a, b
Vessel-wall lesions identified on the precontrast 3 T and 7 T vessel wall
images (arrows), with enhancement (arrowheads) on the postcontrast
images at 3 T and 7 T (a right proximal VA), and 7 T only (b left
proximal VA). c Vessel wall lesion identified based on enhancement of
the vessel wall on the postcontrast 3 T and 7 T vessel wall images (c left
proximal VA). VA vertebral artery
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addition, we can contemplate whether these wall thickenings
might actually reflect normal thickness variation throughout
the intracranial arterial vasculature. Although two recent post-
mortem studies have shown that ultrahigh-resolution 7-TMRI
can identify atherosclerotic plaques in intracranial arteries [14,
28], validation of in vivo MRI results with histology has not
yet been performed. Therefore, we do not really know to what
extent all identified vessel wall lesions in this study are true
atherosclerotic lesions, especially when these lesions are seen
on one field strength only. This makes it difficult to determine
which field strength shows vessel wall lesions best.
One striking secondary result is that in the elderly asymp-
tomatic population included in this study, a substantial amount
of intracranial vessel-wall lesions have been found.Most stud-
ies have attempted to target symptomatic intracranial athero-
sclerosis; until now, only transcranial Doppler has been used
to assess the presence of intracranial atherosclerosis in an
asymptomatic population [29], but this technique solely pro-
vides information about the presence of stenotic lesions, i.e.
advanced atherosclerotic lesions. Previous studies in a
symptomatic patient population with ischaemic stroke/TIA
imaged with the same 7-T MRI sequence found 84 % of
patients had on average three vessel-wall lesions in the circle
of Willis arteries, and 100 % of patients had on average four
lesions if the vertebral arteries were also (mostly) taken into
account [19, 21]. These results show a striking similarity with
our current results of 100 % of subjects with on average five
vessel-wall lesions at 7 T; however, our study population con-
sists of asymptomatic healthy elderly volunteers instead of
patients with symptomatic cerebrovascular disease.
Another striking result is that in our elderly asymptomatic
population, many of the intracranial vessel-wall lesions
showed enhancement after contrast administration, predomi-
nantly at 7 T. Shortening of the T1 relaxation time caused by
the injected contrast agent is suggested to be reduced at higher
field strengths [30]. However, the increased SNR at 7 T may
theoretically make the sequence more sensitive for smaller
amounts of contrast agent, e.g. when present in a vessel wall
lesion. Also, the 7-T sequence used in this study might be
stronger T1-weighted than the 3-T sequence, making the 7-T
Fig. 3 Non-corresponding
intracranial vessel wall lesions
(arrows or arrowheads) identified
on either the 3-T (a, b) or 7-T (c,
d) vessel wall images that were
identified retrospectively on the
other scan: located at the right P1
segment of the PCA (a),
bifurcation BA-P1 (b), right
bifurcation P1-P2 segment of the
PCA (c), and right M1 segment of
the MCA (d). BA basilar artery,
MCA middle cerebral artery, PCA
posterior cerebral artery
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sequence more sensitive for visualising enhancement.
Another possible explanation might be that the time between
contrast administration and acquisition of the postcontrast
vessel-wall scan was not exactly identical during both MRI
examinations [8] (approximately 4 min shorter at 3 T).
Contrast enhancement of intracranial atherosclerotic plaques
has been associated with acute ischaemic stroke [31–33] and
could be a marker for plaque inflammation or neovascularisa-
tion [34], and even potentially of intracranial plaque instability
and stroke risk [33]. Our results, however, show that enhanc-
ing lesions are not always associated with (acute) ischaemic
stroke or plaque inflammation.
The results from this study shed new light on the clinical
application of intracranial vessel wall imaging, and raise im-
portant issues that need to be considered. Currently, differen-
tiation between atherosclerotic lesions and normal vessel-wall
thickness variations resp. (CSF) flow artefacts alongside the
artery walls is difficult. Although much is known already
about in vivo vessel-wall (intima-media) thickness of extra-
cranial arteries [35], limited information is available on
(normal) vessel-wall thickness variations of the arteries of
the circle ofWillis. The current study shows vessel-wall lesion
burden of the asymptomatic population was comparable to
that of symptomatic patients in previous studies. Apart from
being vessel-wall lesions, these wall thickenings could also be
a reflection of ‘normal’ variation in vessel wall thickening
throughout the intracranial arterial vasculature. Therefore,
the clinical relevance of these vessel-wall lesions might be
limited. This may be especially true for enhancing lesions that,
based on our current study, are apparently not always associ-
ated with ischaemic stroke or plaque inflammation, as has thus
far been assumed. Therefore, future studies comparing both
symptomatic and asymptomatic patients should be performed,
to gain more insight into differences of vessel-wall lesion
burden/thickness variations, as well as contrast enhancement
of the vessel wall.
The current study uses a 7-T vessel wall sequence with a
relatively low spatial resolution compared with most pub-
lished (and our own) 3-Tsequence(s). A disadvantage of using
an inversion recovery pulse (for optimal CSF suppression) is
Fig. 4 Non-corresponding
intracranial vessel-wall lesions
(arrows) identified on either the
3-T (a, b) or 7-T (c, d) vessel-wall
images that could also not be
identified on the other field
strength retrospectively: located
at the bifurcation BA-P1 (a
visible at 3 T), left M2 segment of
the MCA (b visible at 3 T), left
M1 segment of the MCA (c
visible at 7 T) and left distal
intracranial segment of the ICA (d
visible at 7 T). BA basilar artery,
ICA internal carotid artery, MCA
middle cerebral artery
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that it increases acquisition time. Therefore, the acquired spatial
resolution of the 7-T sequence used in our study is currently
restricted to 0.8 × 0.8 × 0.8 mm3. As a consequence, some of
the scored vessel wall lesions will be smaller than the true voxel
size of this 7-T sequence (although this is also true for most
used 3-T sequences), since the intracranial vessel wall is typi-
cally very thin. However, a previous study by Kleinloog et al.
[36], in which the same 7-T vessel-wall sequence was used as
in the current study, showed that signal intensity variation of the
vessel wall reflects thickness variation. Therefore, it is possible
to infer thickness variations from the 7-T vessel-wall images
even for vessel walls that are thinner than the acquired voxel
size. Also, the advantage of high image contrast between vessel
wall (lesions) and surrounding tissue at 7 T, due to the applied
inversion recovery pulse, could compensate for, or be even
more important than, spatial resolution for visualising vessel
wall lesions. Although other research groups have reported ves-
sel wall sequences with higher resolutions, they achieved less
optimal CSF suppression [10, 11, 37, 38]. Future work should
be done to evaluate the relative importance of resolution versus
contrast and CSF suppression.
This study has several limitations. First, theMRI sequences
used at both field strengths were not exactly the same: the
main differences were the higher in-plane spatial resolution
of the 3-T sequence and higher through-plane (slice thickness)
spatial resolution of the 7-T sequence, and the lack of an in-
version pulse for CSF suppression at 3 T. However, to achieve
a fair comparison between both field strengths, we found
using optimised imaging sequences for each field strength
the best option. Second, the receive coils used in this study
were different (eight-channel head coil at 3 T versus 32-
channel head coil at 7 T). Third, in this study all minor vessel
wall thickness variations were scored as vessel wall lesions.
As discussed earlier, especially for small vessel wall lesions,
we cannot be certain that these are all actual vessel wall le-
sions; for translation of the vessel wall imaging findings to
clinical practice, as well as usability in future studies, valida-
tion with a Bgold standard^ (histology) is a prerequisite.
Fourth, blinding the raters for field strength was not possible
due to the inherent slightly different image contrast between 3
T and 7 T; this might have induced a bias in image rating.
Fifth, the sample size of this study was relatively small.
However, this is the first study to provide a comparison of 3-
T and 7-T intracranial vessel-wall imaging, as well as vessel-
wall imaging in an asymptomatic elderly population with the
administration of a contrast agent to assess enhancement of
the vessel wall. Lastly, although 7-T MRI is still less available
compared with the lower field strength MR systems, the num-
ber of installed 7-T MR systems has increased in recent years
[39]. Together with the tremendous growth of technical devel-
opments at 7-T MRI over the last decade to overcome diffi-
culties of imaging at higher field strength, its use may become
more broadly available in the near future.
In summary, in this comparative study of a dedicated 3-T
VIRTA and 7-T MPIR-TSE intracranial vessel-wall sequence
in asymptomatic individuals, 7-T vessel-wall imaging appears
to have the highest potential to identify the total burden of
vessel wall lesions in the arteries of the circle of Willis and
its branches. However, a direct comparison between symp-
tomatic and asymptomatic patients is warranted to elucidate
the potential for clinical application of intracranial vessel-wall
imaging.
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